213 157

Cited 22 times in

Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.

Authors
 Joon Soon Kang  ;  Ye Yeon Won  ;  Jong Oh Kim  ;  Byeong Woo Min  ;  Kee Haeng Lee  ;  Kwan Kyu Park  ;  Joo Hyun Song  ;  Young Tae Kim  ;  Geon Ho Kim 
Citation
 INTERNATIONAL ORTHOPAEDICS, Vol.38(6) : 1247-1253, 2014 
Journal Title
 INTERNATIONAL ORTHOPAEDICS 
ISSN
 0341-2695 
Issue Date
2014
MeSH
Adult ; Aged ; Aged, 80 and over ; Bone Density ; Bone Density Conservation Agents/adverse effects* ; Diphosphonates/adverse effects* ; Female ; Femoral Fractures/chemically induced* ; Femoral Fractures/etiology ; Fracture Healing/drug effects ; Fractures, Ununited/chemically induced ; Fractures, Ununited/etiology ; Humans ; Male ; Middle Aged ; Osteoporosis/complications ; Osteoporosis/drug therapy ; Osteoporotic Fractures/chemically induced ; Osteoporotic Fractures/etiology ; Retrospective Studies ; Time Factors
Keywords
Atypical femoral fracture ; Osteoporosis ; Bisphosphonates ; Delayed union
Abstract
PURPOSE: Increasing numbers of atypical femoral fractures have been reported among long-term bisphosphonate users. We evaluated clinical characteristics of atypical femoral fractures throughout Korean multicenter studies. METHODS: We retrospectively analysed the bone mineral density, prodromal symptoms before femoral fracture, and medication history of osteoporosis in 76 cases of atypical femoral fracture. RESULTS: The mean age of cases was 71.4 ± 8.8 (range, 43-89) years old. The mean follow-up period after the fracture operation was 24.5 ± 12.9 (range, 12-79) months. BMI was 23.2 ± 3.0 on average. The mean BMD of femur was -1.9 ± 1.4 (range, -4.8 to 1.3). Prodromal symptoms including thigh pain before femoral fracture appeared in 22 (28.9 %) of 76 patients. All patients included in the study used bisphosphonate. The duration of taking bisphosphonate before fracture was 36.8 ± 50.8 (one-204 months) months. Fifty-seven (75 %) of 76 patients were taking the medication for more than three years. Delayed union occurred in 43 (56.5 %) of 76 patients. Delayed union was defined as a fractured bone that did not completely heal within six months of injury. The group of having taken anti-osteoporotic medication for more than three years showed relatively longer union period compared to that for a shorter period medication group (4.8 ± 2.5 months vs 9.3 ± 3.7 months, p = 0.017). The delayed union developed in 43 (56.5 %) of 76 patients and showed a significantly higher incidence in the group with long-term therapy (five/43 vs 38/43, p = 0.021). The bilateral femoral fractures developed in 23 (30.2 %) of 76 patients and showed a high incidence in the group medicated more than three years (two/23 vs 21/23, p = 0.039). CONCLUSIONS: The longer bisphosphonates are used, the more the cases of delayed union and the more frequent the development of bilateral fractures following unilateral fractures. With regard to the delayed union, the methods of the acceleration of fracture healing may be beneficial in atypical femoral fracture patients who had been receiving long-term bisphosphonates therapy. Careful observation is required for contra-lateral femurs due to a high incidence of bilateral atypical femoral fractures.
Files in This Item:
T201404670.pdf Download
DOI
10.1007/s00264-013-2259-9
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Orthopedic Surgery (정형외과학교실) > 1. Journal Papers
Yonsei Authors
Park, Kwan Kyu(박관규) ORCID logo https://orcid.org/0000-0003-0514-3257
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/138488
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse